CSHNX
Price
$12.51
Change
+$0.06 (+0.48%)
Updated
Jan 17 closing price
Net Assets
1.17B
EIPFX
Price
$18.73
Change
+$0.08 (+0.43%)
Updated
Jan 17 closing price
Net Assets
82.09M
Ad is loading...

CSHNX vs EIPFX

Header iconCSHNX vs EIPFX Comparison
Open Charts CSHNX vs EIPFXBanner chart's image
NYLI Cushing® MLP Premier Investor Class
Price$12.51
Change+$0.06 (+0.48%)
VolumeN/A
Net Assets1.17B
EIP Growth and Income Investor
Price$18.73
Change+$0.08 (+0.43%)
VolumeN/A
Net Assets82.09M
CSHNX vs EIPFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSHNX vs. EIPFX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSHNX is a Hold and EIPFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSHNX has more cash in the bank: 1.17B vs. EIPFX (82.1M). CSHNX pays higher dividends than EIPFX: CSHNX (7.86) vs EIPFX (3.31). CSHNX was incepted earlier than EIPFX: CSHNX (11 years) vs EIPFX (8 years). CSHNX (2500) and EIPFX (2500) have matching initial minimum investment requirements. CSHNX annual gain was more profitable for investors over the last year : 57.33 vs. EIPFX (31.91). CSHNX return over 5 years is better than : 85.63 vs. EIPFX (41.04).
CSHNXEIPFXCSHNX / EIPFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years8 years-
Gain YTD9.5455.786165%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B82.1M1,421%
Annual Yield % from dividends7.863.31238%
Returns for 1 year57.3331.91180%
Returns for 3 years104.9028.56367%
Returns for 5 years85.6341.04209%
Returns for 10 years34.46N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARWR19.560.54
+2.84%
Arrowhead Pharmaceuticals
AXR32.780.51
+1.58%
AMREP Corp
SNN25.290.24
+0.96%
Smith & Nephew plc
CTLP8.150.04
+0.49%
Cantaloupe
VRPX0.30-0.01
-2.06%
Virpax Pharmaceuticals